Hookah Cousins LLC

WARNING LETTER Hookah Cousins LLC MARCS-CMS 592381 — February 06, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Product: Tobacco Recipient: Recipient Name Hatem Alami and Tarik Ansari Hookah Cousins LLC 4299 S. Alton St. Greenwood Village , CO 80111 United States Hatem@hookahcousins.com hatemalami@gmail.com sales@hookahcousins.com Issuing Office: Center for Tobacco Products 10903 New Hampshire Avenue Silver Spring , MD 20993 United States FEB 6, 2020 WARNING LETTER Dear Hatem Alami and Tarik Ansari: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://hookahcousins.com and determined that the waterpipe tobacco products listed there are advertised and offered for sale or distribution to customers in the United States. Under section 201 (rr) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. § 321(rr)), as amended by the Family Smoking Prevention and Tobacco Control Act, these products are tobacco products because they are made or derived from tobacco and intended for human consumption. Certain tobacco products, including waterpipe tobacco, are subject to FDA jurisdiction under section 901(b} of the FD&C Act (21 U.S.C. § 387a(b)). FDA has determined that several waterpipe tobacco products advertised and offered for sale or distribution on your website are misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)) because your website advertising the waterpipe tobacco products fails to adequately display the required nicotine warning statement. Waterpipe Tobacco Products with Advertising that Fails to Adequately Display the Required Nicotine Warning Statement are Misbranded Our review of the website https://hookahcousins.com revealed that the advertising for several waterpipe tobacco products that you sell, offer for sale or distribute in the United States does not display the required nicotine warning statement in the manner required by 21 C.F.R. § 1143.3(b)(2), for example: Starbuzz Sex on the Beach, Alchemist Straight Blueberry, and Social Smoke Sex Panther. The required nicotine warning statement for such advertisements must comply with 21 C.F.R. § 1143.3(b}(2), such as, being conspicuous, surrounded by a rectangular border, and occupying at least 20 percent of the area of the advertisement. Under 21 C.F .R. § 1143.3(b}, advertising for cigarette tobacco, roll-your-own tobacco, and covered tobacco products (other than cigars), such as waterpipe tobacco products, must bear the following warning statement: WARNING: This product contains nicotine. Nicotine is an addictive chemical. For cigarette tobacco, roll-your-own tobacco, and covered tobacco products other than cigars, it is unlawful for a tobacco product manufacturer, packager, importer, distributor, or retailer of the tobacco product to advertise or cause to be advertised within the United States any tobacco product unless each advertisement bears the required warning statement (21 C.F .R. § 1143.3(b )(1 )). Further, the required warning statement must meet the requirements of21 C.F.R. § 1143.3(b)(2). Under 21 C.F.R. § 1143.1 , a "covered tobacco product" is defined as any tobacco product deemed to be subject to the FD&C Act under 21 C.F.R. § 1100.2, excluding components or parts not made or derived from tobacco. Before 21 C.F .R. § 1100.2 became effective, only cigarettes, smokeless tobacco, roll-your-own tobacco, and cigarette tobacco were subject to chapter IX of the FD&C Act. 21 C.F.R. § 1100.2 deems all other tobacco products, except accessories of such tobacco products, subject to chapter IX and its implementing regulations. The products cited in this violation are "covered tobacco products." Under section 903{a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)), tobacco products are misbranded if sold or distributed in violation of regulations prescribed under section 906(d) of the FD&C Act, including those within 21 C.F.R. Part 1143. Because your website regarding waterpipe tobacco products does not display the required nicotine warning statement in a manner consistent with the requirements of 21 C.F.R. § 1143.3{b)(2), your waterpipe tobacco products are misbranded under section 903{a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)). Conclusion and Requested Actions The violation discussed in this letter does not necessarily constitute an exhaustive list. You should immediately correct the violation that is referenced above, as well as violations that are the same as or similar to the one stated above, and take any necessary actions to bring your tobacco products into compliance with the FD&C Act. It is your responsibility to ensure that your tobacco products and all related labeling and/or advertising on this website, on any other websites (including e-commerce, social networking, or search engine websites), in any other media in which you advertise, and in any retail establishments comply with each applicable provision of the FD&C Act and FDA's implementing regulations. Failure to ensure full compliance with the FD&C Act may result in FDA initiating further action without notice, including, but not limited to, civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Please note that any adulterated and/or misbranded tobacco products offered for import into the United States are subject to detention and refusal of admission. Please submit a written response to this letter within 15 working days from the date of receipt describing your corrective actions, including the dates on which you discontinued the violative labeling, advertising, sale, and/or distribution of these tobacco products and your plan for maintaining compliance with the FD&C Act. If you do not believe that your products are in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. You can find the FD&C Act through links on FDA's homepage at http://www.fda.gov . Please note your reference number, RW1901180, in your response and direct your response to the following address: DPAL-WL Response, Office of Compliance and Enforcement FDA Center for Tobacco Products c/o Document Control Center Building 71 , Room G335 10903 New Hampshire Avenue Silver Spring, MD 20993-0002 If you have any questions about the content of this letter, please contact Ele Ibarra-Pratt at (301) 796-9235 or via email at CTPCompliance@fda.hhs.gov. Sincerely, /S/ Ann Simoneau, J.D. Director Office of Compliance and Enforcement Center for Tobacco Products VIA Electronic Mail cc: GoDaddy.com, LLC abuse@qodaddy.com Tucows Domains Inc. domainabuse@tucows.com Content current as of: 02/18/2020 Regulated Product(s) Tobacco